Neuphoria Therapeutics NEUP Cash Flow Statement (2023-2026)

NASDAQ NEUP
$3.95 +0.02 (+0.51%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -5.47M-4.55M-2.78M-2.31M-0.80M-1.94M11.26M-2.24M-9.91M1.86M-0.51M
Share-based Compensation (Quarter) 0.14M0.75M0.04M0.11M0.03M0.02M0.02M0.13M0.11M0.09M0.07M
Deferred Taxes (Quarter) -0.03M-0.03M-0.03M-0.03M-0.13M0.01M-0.08M-0.27M-0.03M-0.03M-0.03M
Gains from Investment Securities (Quarter) 0.12M-0.11M0.57M-2.45M-2.97M3.13M-2.94M1.81M4.39M-5.38M0.84M
Cash from Operations (Quarter) -4.43M-3.95M-3.30M-3.01M-4.43M-3.36M11.45M-3.56M-3.80M-6.40M-3.40M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter) 0.17M0.17M0.17M0.17M0.17M0.17M0.17M0.17M0.17M0.17M0.17M
Change in Working Capital
Change in Receivables (Quarter) 0.02M-0.33M-0.01M0.02M-0.01M-0.08M-0.01M-0.01M-0.01M1.11M0.50M
Change in Account Payables (Quarter) 0.88M-0.87M-0.87M1.66M-0.92M0.20M-0.79M0.58M0.22M-0.85M0.11M
Change in Accured Expenses (Quarter) -0.70M0.96M-0.47M0.50M-0.37M-0.79M0.38M2.27M0.72M-1.60M-1.18M
Other Working Capital Changes (Quarter) -0.43M0.56M-0.30M-0.17M-0.23M-0.21M0.00M-0.52M-0.20M0.58M
Financing Activities
Other financing activities (Quarter) 409.00
Cash from Financing Activities (Quarter) 0.61M5.63M1.75M7.12M-0.23M-0.11M1.16M0.70M3.25M14.66M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter) 6.26M0.29M1.44M2.12M0.82M0.70M3.25M14.66M
Additional items
Exchange Rate Effect (Quarter) -0.15M0.34M-0.19M0.07M0.14M-0.28M0.08M0.05M-0.02M0.30M0.53M
Change in Cash (Quarter) -3.82M1.87M-1.73M4.18M-4.52M-3.75M12.70M-2.83M-0.56M8.52M-2.81M
Free Cash Flow (Quarter) -4.43M-3.95M-3.30M-3.01M-4.43M-3.36M11.45M-3.56M-3.80M-6.40M-3.40M
Net Cash Flow (Quarter) -3.82M1.68M-1.55M4.11M-4.66M-3.47M12.62M-2.86M-0.55M8.26M-3.40M